1. Home
  2. PDLB vs OCGN Comparison

PDLB vs OCGN Comparison

Compare PDLB & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ponce Financial Group Inc.

PDLB

Ponce Financial Group Inc.

HOLD

Current Price

$16.65

Market Cap

405.9M

Sector

N/A

ML Signal

HOLD

Logo Ocugen Inc.

OCGN

Ocugen Inc.

HOLD

Current Price

$1.95

Market Cap

387.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDLB
OCGN
Founded
1960
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
405.9M
387.3M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
PDLB
OCGN
Price
$16.65
$1.95
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$9.75
AVG Volume (30 Days)
63.2K
10.3M
Earning Date
04-24-2026
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
160.87
31.58
EPS
1.20
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2,980.89
P/E Ratio
$13.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.88
$0.57
52 Week High
$18.01
$2.73

Technical Indicators

Market Signals
Indicator
PDLB
OCGN
Relative Strength Index (RSI) 56.18 50.70
Support Level $15.84 $1.47
Resistance Level $17.29 $2.73
Average True Range (ATR) 0.35 0.23
MACD 0.04 -0.04
Stochastic Oscillator 65.77 33.33

Price Performance

Historical Comparison
PDLB
OCGN

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Share on Social Networks: